Location History:
- Wilmington, MA (US) (2020 - 2022)
- Medford, MA (US) (2014 - 2024)
Company Filing History:
Years Active: 2014-2025
Title: The Innovative Journey of Lori Ann Ferris
Introduction
Lori Ann Ferris is a notable inventor based in Medford, MA, holding an impressive portfolio of 10 patents. Her significant contributions to the field of pharmaceutical compositions highlight her dedication to advancing medical treatments, particularly for cystic fibrosis.
Latest Patents
Ferris's most recent innovations focus on the treatment of cystic fibrosis transmembrane conductance regulator (CFTR) mediated diseases. One of her latest patents features compositions that include a plurality of therapeutic agents, where the presence of one agent enhances the properties of another. This innovative approach is exemplified through the development of CFTR correctors and potentiators, aimed at treating CFTR mediated diseases like cystic fibrosis. Additionally, she has patented a modulator of the CFTR, detailing compounds, pharmaceutical compositions, and methods for treatment, further solidifying her role in enhancing therapeutic strategies for cystic fibrosis.
Career Highlights
Throughout her career, Lori Ann Ferris has collaborated with prominent companies in the pharmaceutical industry, including Vertex Pharmaceuticals, Inc. and Alios Biopharma, Inc. Her work has significantly influenced the research and development of treatments targeting complex medical conditions.
Collaborations
In her journey as an inventor, Ferris has collaborated with talented professionals such as Ales Medek and Eleni Dokou. These partnerships have facilitated the exchange of innovative ideas, driving advancements in their shared field of expertise.
Conclusion
Lori Ann Ferris exemplifies innovation in the medical field, with a strong focus on developing treatments for cystic fibrosis. Her extensive patent portfolio reflects her commitment to improving patient outcomes and advancing medical science. Through her work, Ferris continues to inspire the next generation of inventors and researchers.